In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...

FORT MILL, SC / ACCESSWIRE / / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company ...

Adaptive cardiac devices are transforming the treatment of heart disease by enabling real-time monitoring and adaptive therapy adjustments. With their ability to provide continuous and accurate ...

SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today an ...

FIRE1 has raised $120m in a financing round to advance its sensor that monitors important warning signs of heart failure (HF) ...

Peerbridge health has announced the launch of its landmark COR-INSIGHT Trial, which will validate the screening and diagnostic capabilities of its Peerbridge Cor® ambulatory ECG wearables. The trial ...

In a ground-breaking medical achievement, a multidisciplinary team of doctors at Rainbow Children’s Heart Institute, an exclusive pediatric heart centre has successfully performed a fetal balloon ...

Prytime Medical, The REBOA Company™ , proudly announces the first civilian use of its pREBOA-PRO™ catheter in the European Union, following the device's receipt of CE Mark approval.

“On January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and ...

Adaptive cardiac devices are revolutionising heart disease treatment for real-time monitoring and dynamic therapy adjustments. By offering continuous, precise interventions, these innovations in ...

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

What are the future trends of medical devices? In the rapidly evolving landscape of healthcare, staying informed about the latest advancements in medical technology is essential for professionals and ...